Arkolith/Insider Trading/LTRN/Form 4

Keyser D Jeffrey

DirectorLantern Pharma Inc. (LTRN) · full profile →Form 4 · filed Jul 26, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 24, 2024Option exercise(X)4K$3.13$12K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 24, 2024Option exercise(X)4K—$00

Transaction Codes

X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-029238) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML